Published in BMC Cardiovasc Disord on September 17, 2012
Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol (2007) 3.13
Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J Biol Chem (2001) 2.12
Smoking and smoking cessation -- the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis (2008) 1.92
Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol (2009) 1.74
Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis (2003) 1.64
Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Curr Atheroscler Rep (2009) 1.26
The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers (2009) 1.24
Osteopontin and cardiovascular system. Mol Cell Biochem (2006) 1.24
Osteopontin: a novel inflammatory mediator of cardiovascular disease. Front Biosci (2007) 1.00
Osteopontin in cardiovascular disease: a potential therapeutic target. Cardiol Rev (2010) 0.99
Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease. Cardiovasc Res (2007) 0.94
Distinct regulatory profiles of interleukins and chemokines in response to cigarette smoke condensate in normal human bronchial epithelial (NHBE) cells. J Interferon Cytokine Res (2008) 0.92
Macromolecules in bone matrix. Connect Tissue Res (1989) 0.91
Smoking, smoking cessation and inflammatory markers in older Chinese men: The Guangzhou Biobank Cohort Study. Atherosclerosis (2008) 0.91
Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease. Scand J Clin Lab Invest (2007) 0.90
Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane). Thromb Res (2000) 0.90
Cigarette smoke alters tissue inhibitor of metalloproteinase 1 and matrix metalloproteinase 9 levels in the basolateral secretions of human asthmatic bronchial epithelium in vitro. J Investig Med (2010) 0.88
Agents associated with lung inflammation induce similar responses in NCI-H292 lung epithelial cells. Toxicol In Vitro (2008) 0.85
Cigarette smoke exposure inhibits extracellular MMP-2 (gelatinase A) activity in human lung fibroblasts. Respir Res (2007) 0.85
Effect of giving up cigarette smoking and restarting in patients with clinically manifested atherosclerosis. Prostaglandins Leukot Essent Fatty Acids (2002) 0.85
Smoking and atherosclerotic cardiovascular disease: Part I: atherosclerotic disease process. Biomark Med (2009) 0.81
Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron (2006) 2.53
Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet (2008) 2.24
Peroxynitrite formation mediates LPC-induced augmentation of cardiac late sodium currents. J Mol Cell Cardiol (2007) 1.45
Atrial glutathione content, calcium current, and contractility. J Biol Chem (2007) 1.19
H2O2 regulates recombinant Ca2+ channel alpha1C subunits but does not mediate their sensitivity to acute hypoxia. Biochem Biophys Res Commun (2004) 1.04
Presynaptic modulation of rat arterial chemoreceptor function by 5-HT: role of K+ channel inhibition via protein kinase C. J Physiol (2003) 0.97
Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels. FASEB J (2004) 0.96
Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease. J Neuroimmunol (2005) 0.90
Calcium-activated K+ channels increase cell proliferation independent of K+ conductance. Am J Physiol Cell Physiol (2010) 0.90
A novel O2-sensing mechanism in rat glossopharyngeal neurones mediated by a halothane-inhibitable background K+ conductance. J Physiol (2003) 0.89
Neuroepithelial oxygen chemoreceptors of the zebrafish gill. J Physiol (2004) 0.89
System-specific O2 sensitivity of the tandem pore domain K+ channel TASK-1. Am J Physiol Cell Physiol (2003) 0.84
Hypoxic augmentation of Ca2+ channel currents requires a functional electron transport chain. J Biol Chem (2005) 0.81
Sorcin modulates cardiac L-type Ca2+ current by functional interaction with the alpha1C subunit in rabbits. Exp Physiol (2008) 0.79
O2-sensing mechanisms in efferent neurons to the rat carotid body. Adv Exp Med Biol (2003) 0.79
A central role for ROS in the functional remodelling of L-type Ca2+ channels by hypoxia. Philos Trans R Soc Lond B Biol Sci (2005) 0.79
Analysis of oxygen-sensitive human cardiac L-type Ca2+ channel alpha1C subunit (hHT Isoform). Methods Enzymol (2004) 0.78
Differential regulation of calcium-activated potassium channels by dynamic intracellular calcium signals. J Membr Biol (2010) 0.76
An in vitro perfusion system to examine the responses of endothelial cells to simulated flow and inflammatory stimulation. Altern Lab Anim (2009) 0.76
Amyloid beta peptides mediate physiological remodelling of the acute O2 sensitivity of adrenomedullary chromaffin cells following chronic hypoxia. Cardiovasc Res (2004) 0.75
Potential oxygen sensing pathways in the zebrafish gill. Adv Exp Med Biol (2003) 0.75
GABA(B) receptor activation augments TASK-1 in MAH cells and mediates autoreceptor feedback during hypoxia. Biochem Biophys Res Commun (2003) 0.75